CUE
Cue Biopharma
27.70$
+23.9%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | 3,046.6% | 3,147.7% | 2,296.9% | 2,063.8% | 2,257.6% | 650.9% | 538.8% | 663.7% | 1,100.7% | 755.3% | 1,067.8% | 1,683.8% | 632.1% | 319.9% | 471.3% | 139.3% | 1,008.2% | 36,892.3% | 11,133.8% | 5,330.5% | 470.6% | 61.4% | 427.3% | 740.6% | 49.4% | 358.5% | – | – | – | 3.4% | 3.7% | 14.6% | 1.4% | 0.5% | 9.0% | |
| – | – | – | – | – | – | -3,046.6% | -3,047.7% | -2,196.9% | -1,963.8% | -2,157.6% | -550.9% | -438.8% | -563.7% | -1,000.7% | -655.3% | -967.8% | -1,583.8% | -532.1% | -219.9% | -371.3% | -39.3% | -908.2% | -36,792.3% | -11,033.8% | -5,230.5% | 100.0% | 100.0% | -327.3% | -640.6% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 96.3% | 100.0% | 100.0% | 99.5% | 99.7% | |
| – | – | – | – | – | – | 3,046.6% | 3,147.7% | 2,296.9% | 2,063.8% | 2,257.6% | 650.9% | 538.8% | 663.7% | 1,100.7% | 755.3% | 1,067.8% | 1,683.8% | 632.1% | 319.9% | 471.3% | 139.3% | 1,008.2% | 36,892.3% | 11,133.8% | 7,504.6% | 5,021.9% | 770.6% | 470.2% | 597.9% | 594.0% | 358.5% | 281.2% | 455.8% | 2,030.2% | 267.8% | 218.1% | 75.3% | 121.3% | 622.2% | 204.8% | |
| – | – | – | – | – | – | 891.6% | 1,296.5% | 644.8% | 1,353.3% | 930.8% | 324.1% | 282.1% | 272.2% | 414.7% | 338.5% | 429.1% | 668.6% | 256.6% | 146.5% | 161.3% | 52.9% | 486.9% | 13,600.0% | 4,920.6% | 2,331.8% | 2,233.2% | 307.5% | 173.6% | 253.1% | 243.8% | 131.9% | 85.9% | 255.1% | 991.2% | 124.4% | 229.3% | 15.7% | 73.0% | 591.2% | 156.9% | |
| – | – | – | – | – | – | 3,938.2% | 4,444.2% | 2,941.6% | 3,417.2% | 3,188.4% | 975.0% | 820.9% | 295.4% | 443.2% | 362.6% | 471.3% | 725.0% | 274.0% | 156.3% | 172.2% | 56.3% | 515.6% | 13,553.8% | 5,188.2% | 4,614.6% | 7,255.1% | 1,078.1% | 216.4% | 118.9% | 837.8% | 490.6% | 364.2% | 711.2% | 3,021.4% | 392.3% | 447.4% | 91.1% | 194.3% | 1,213.3% | 361.8% | |
| – | – | – | – | – | – | -3,938.2% | -4,344.2% | -2,841.6% | -3,317.2% | -3,088.4% | -875.0% | -720.9% | -859.1% | -1,443.9% | -1,017.9% | -1,439.1% | -2,308.9% | -806.1% | -376.2% | -543.5% | -95.6% | -1,423.8% | -50,346.2% | -16,222.1% | -9,845.0% | -7,155.1% | -978.1% | -543.8% | -759.6% | -737.8% | -390.6% | -264.2% | -611.2% | -2,921.4% | -292.3% | -351.0% | 8.9% | -94.3% | -1,113.3% | -262.0% | |
| – | – | – | – | – | – | 0.0% | 98.8% | 22.7% | 0.0% | 30.8% | 9.1% | 10.1% | – | 2.9% | 2.3% | 3.3% | 0.8% | 0.8% | 0.9% | 1.0% | 0.0% | 2.5% | 792.3% | 182.4% | 237.6% | 197.9% | 16.8% | 13.6% | 27.8% | 14.0% | 8.1% | 5.6% | 9.7% | 30.4% | 1.5% | 3.5% | 0.2% | 0.1% | 0.1% | 0.4% | |
| – | – | – | – | – | – | -3,938.7% | -4,244.2% | -2,797.1% | -3,265.6% | -3,045.1% | -863.4% | -710.4% | 849.8% | -1,424.2% | -1,007.7% | -1,424.9% | -2,292.5% | -805.2% | -375.3% | -542.5% | -95.6% | -1,425.5% | -50,800.0% | -16,110.3% | -9,663.6% | -7,010.2% | -954.1% | -524.0% | -737.7% | -719.1% | -382.7% | -259.6% | -602.5% | -2,911.4% | -287.1% | -346.6% | 9.5% | -91.1% | -1,943.2% | -434.5% | |
| – | – | – | – | – | – | 0.0% | -98.8% | -22.7% | -249,543.3% | -30.8% | 39.1% | -10.1% | 0.0% | -22.6% | 57.5% | -17.5% | 43.4% | 13.3% | – | 0.1% | 6.0% | 1.7% | 453.8% | -111.8% | -91.7% | 52.9% | 40.8% | 33.3% | 44.3% | 46.9% | – | -259.6% | – | – | – | – | 2.3% | – | – | – | |
| – | – | – | – | – | – | -3,938.7% | -4,244.2% | -2,797.1% | -3,515.2% | -3,045.1% | -902.6% | -710.4% | -849.8% | -1,424.2% | -1,007.7% | -1,424.9% | -2,335.9% | -805.2% | -375.3% | -542.5% | -101.6% | -1,425.5% | -50,800.0% | -16,110.3% | -9,663.6% | -7,010.2% | -954.1% | -524.0% | -737.7% | -719.1% | -382.7% | -259.6% | -602.5% | -2,911.4% | -287.1% | -346.6% | 7.2% | -91.1% | -1,943.2% | -435.8% | |
| – | – | – | – | – | – | -3,850.8% | -4,230.8% | -2,798.4% | -3,255.4% | -2,762.4% | -768.5% | -701.1% | -839.5% | -1,414.7% | -992.6% | -1,400.9% | -2,255.5% | -785.6% | -363.8% | -529.3% | -91.8% | -1,392.7% | -50,511.5% | -15,632.4% | -9,723.2% | -6,341.7% | -875.8% | -504.2% | -744.8% | -655.6% | -342.0% | -227.7% | -586.6% | -2,671.5% | -258.7% | -339.4% | 15.2% | -74.7% | -1,113.3% | -254.7% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.